Article History
Received: 20 January 2019
Accepted: 14 August 2019
First Online: 3 September 2019
Ethics approval and consent to participate
: Not Applicable
: Not Applicable
: Peter Paul Yu: no competing interests, Omar Eton: Dr. Eton participates in the Merck speakers bureau and is an investigator on a BMS clinical trial, Louis P. Garrison: Professor Garrison has provided economic consultation and participated in advisory boards for several companies with an interest in IO products, including BMS, Pfizer, Roche, MSD and Novartis. He is currently a member of the ASCO Methodology Working Group for Value in Cancer Care Task Force.